The Valley Desk

NCT05156320 · Interventional trial

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Overall registry status Completed

Phase 3

Conditions Anti-myostatin, Atrophy, Muscular Atrophy, Muscular Atrophy, Spinal, Neuromuscular Diseases, Neuromuscular Manifestations, SMA, Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy Type 3

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov